Delivery Order SPE2DB20D2104-SPE2DB24FS63B
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Topamax 25 mg sprinkle capsules, a medication commonly used to treat epilepsy and migraines. The contract has a firm-fixed price of $2,533.86 and a performance period ending on June 27, 2025. This order is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,531.25, is for the delivery of Topamax 25 mg sprinkle capsules, a medication used to treat certain types of seizures. The contract has a firm fixed-price pricing type and an ultimate completion date of April 7, 2025. This award is not associated with a set-aside program. Amerisourcebergen...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Topamax 25 mg sprinkle capsules. The contract is a firm-fixed price, delivery order type with a ceiling value of $5,919.42 and a period of performance through July 3, 2024. The contract does not have a set-aside designation, indicating open competition. As a key supplier to federal healthcare programs, AmerisourceBergen holds a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,198,715 units of the drug Topamax 25 mg sprinkle capsules. The contract has a ceiling value of $7,883.61 and runs from the award date of October 24, 2024 through the ultimate completion date of October 25, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation indicated. AmerisourceBergen also...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Topamax 25 mg sprinkle capsules. The contract is a firm-fixed-price delivery order with a ceiling value of $2,500.36 and an ultimate completion date of August 7, 2024. The award does not utilize any set-asides. Amerisourcebergen, through its Corporate Office division, is a leading supplier of pharmaceutical products and medical supplies to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Topamax 15 mg sprinkle capsules. The contract, valued at $2,165.14, has a completion date of December 5, 2024 and uses a firm fixed price pricing type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Topamax 15 mg sprinkle capsules. The contract has a ceiling value of $3,286.93 and a period of performance through September 24, 2024. The contract is a firm-fixed-price contract type, and there is no set-aside designation. This award is likely part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TOPAMAX 25 MG SPRINKLE CAP 60S. The contract has a ceiling value of $3,040.35 and a completion date of May 21, 2024. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award, valued at $1,220.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Topamax 15 mg sprinkle capsules, a medication typically used to treat seizures and migraines. This is a delivery order contract with a firm fixed price, and the ultimate completion date is January 31, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Topamax 100 mg tablets, a medication used to treat neurological conditions. The contract has a firm fixed price, a ceiling value of $3,045.01, and a performance period ending on April 30, 2025. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FS63BDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Topamax 25 mg sprinkle capsules, a prescription medication used to treat certain types of seizures. The contract has a ceiling value of $3,593.86 and a completion date of February 20, 2024. It is a firm-fixed-price contract, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 2/16/24 |